Curaleaf Holdings (CURLF) Cash from Operations (2019 - 2024)
Curaleaf Holdings (CURLF) posted quarterly Cash from Operations of 48107000.0 for Q4 2024, up 251.12% year-over-year from 13701000.0 in Q1 2024, and up 13.54% quarter-over-quarter from 42370000.0 in Q3 2024.
Curaleaf Holdings (CURLF) Cash from Operations (2019 - 2024) Analysis & Trends
Curaleaf Holdings' Cash from Operations history runs 6 years deep, the most recent figure standing at 48107000.0 for Q4 2024.
- In Q4 2024, Cash from Operations rose 251.12% year-over-year to 48107000.0; the TTM figure through Dec 2024 stood at 163624000.0 (up 117.41% YoY), while the FY2025 annual figure was 137706000.0, down 15.84% from the prior year.
- Cash from Operations for Q4 2024 stood at 48107000.0, up from 42370000.0 in the prior quarter.
- The five-year high for Cash from Operations was 43776000000.0 in Q1 2024, with the low at 43702853000.0 in Q2 2024.
- The 5-year median for Cash from Operations is 21307500.0 (2020), against an average of 14466781.25.
- The sharpest annual moves came in 2021 and 2023: Cash from Operations jumped 180448.47% in 2021, then slumped 11641.34% in 2023.
- Curaleaf Holdings' Cash from Operations stood at 19166000.0 in 2020, then slumped by 260.88% to 30835000.0 in 2021, then soared by 208.38% to 33418000.0 in 2022, then sank by 59.0% to 13701000.0 in 2023, then soared by 251.12% to 48107000.0 in 2024.
- Business Quant data shows CURLF's Cash from Operations at 48107000.0 in Q4 2024, 42370000.0 in Q3 2024, and 43702853000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 48.11 Mn |
| Dec 31, 2024 | 48.11 Mn |
| Sep 30, 2024 | 42.37 Mn |
| Sep 30, 2024 | 42.37 Mn |
| Jun 30, 2024 | -43.70 Bn |
| Jun 30, 2024 | -43.70 Bn |
| Mar 31, 2024 | 43.78 Bn |
| Mar 31, 2024 | 43.78 Bn |
| Dec 31, 2023 | 13.70 Mn |
| Dec 31, 2023 | 13.70 Mn |
| Sep 30, 2023 | 46.82 Mn |
| Sep 30, 2023 | 46.82 Mn |
| Jun 30, 2023 | -7.88 Bn |
| Jun 30, 2023 | -7.88 Bn |
| Mar 31, 2023 | 7.90 Bn |
| Mar 31, 2023 | 7.90 Bn |
| Dec 31, 2022 | 33.42 Mn |
| Dec 31, 2022 | 33.42 Mn |
| Sep 30, 2022 | 43.98 Mn |
| Sep 30, 2022 | 43.98 Mn |